Request Deal Involvement

Novartis completed its $5.3bn acquisition of Xiidra.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Freshfields Bruckhaus Deringer

legal advisors

Freshfields Bruckhaus Deringer

Evercore

financial advisors

Evercore

Davis Polk & Wardwell

legal advisors

Davis Polk & Wardwell

Sard Verbinnen & Co

pr advisors

Sard Verbinnen & Co

Baker McKenzie

legal advisors

Baker McKenzie

Nishimura & Asahi

legal advisors

Nishimura & Asahi

or

Principals

XIIDRA

target

XIIDRA

NOVARTIS AG

bidder

NOVARTIS AG

TAKEDA PHARMACEUTICAL COMPANY LIMITED

vendor

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Novartis completed its $5.3bn acquisition of Xiidra.